论文部分内容阅读
目的探讨环孢菌素A联合康力龙治疗慢性再生障碍性贫血(CAA)的疗效。方法采用随机对照研究方法比较单用康力龙及康力龙联合环孢菌素A治疗CAA的疗效。结果环孢菌素A联合康力龙治疗组总有效率84.6%,明显高于单用康力龙对照组54.2%。结论环孢菌素A联合康力龙治疗CAA疗效优于单用康力龙治疗组。
Objective To investigate the efficacy of cyclosporine A combined with Kang Lilong in treating chronic aplastic anemia (CAA). Methods A randomized controlled study was conducted to compare the curative effect of single use of KangLongLong and KangLongLong combined with cyclosporine A in the treatment of CAA. Results The total effective rate of cyclosporin A combined with Kang Lilong was 84.6%, which was significantly higher than that of the control group with only Kang Lilong (54.2%). Conclusion The combination of cyclosporin A and KangLongLong is superior to KangLongLong alone in the treatment of CAA.